Radiation-induced morphea of the breast – characterization and treatment of fibroblast dysfunction with repurposed mesalazine
Open Access
- 30 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Abstract
Radiation-induced morphea (RIM) is a rare complication of radiotherapy presenting as inflammatory fibrosis, most commonly reported in breast cancer patients. As underlying disease mechanisms are not well understood, targeted therapies are lacking. Since fibroblasts are the key mediators of all fibroproliferative diseases, this study aimed to characterize patient-derived fibroblasts to identify therapeutic targets. We studied primary human control and RIM-fibroblasts on a functional and molecular basis, analyzed peripheral blood and tissue samples and conducted, based on our findings, a treatment attempt in one patient. In RIM, we identified a distinct myofibroblast phenotype reflected by increased alpha-smooth-muscle-actin (αSMA) expression, reduced proliferation and migration rates, and overexpression of osteopontin (OPN). Our RNA sequencing identified aberrant Myc activation as a potential disease driver in RIM fibroblasts, similar to previous findings in systemic sclerosis. Treatment with the anti-inflammatory drug mesalazine reversed the myofibroblast phenotype by targeting Myc. Based on these findings, a patient with RIM was successfully treated with mesalazine, resulting in reduced inflammation and pain and tissue softening, while serum OPN was halved. The present study provides a comprehensive characterization of RIM fibroblasts, suggests a disease-driving role for Myc, demonstrates promising antifibrotic effects of mesalazine and proposes OPN as a biomarker for RIM.Keywords
Funding Information
- Technische Universität Dresden
This publication has 76 references indexed in Scilit:
- The critical role of osteopontin (OPN) in fibrotic diseasesCytokine & Growth Factor Reviews, 2023
- C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1Cellular Signalling, 2022
- Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient miceNaunyn-Schmiedeberg's Archives of Pharmacology, 2021
- Repurposing mesalazine against cardiac fibrosis in vitroNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Modeling atrial fibrosis in vitro —Generation and characterization of a novel human atrial fibroblast cell lineFEBS Open Bio, 2020
- Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in ratsChemico-Biological Interactions, 2018
- Underdiagnosed and disfiguring - Radiation-induced morphea following breast cancer treatmentThe Breast, 2018
- Radiation-Induced Morphea: An Under-Recognized Complication of Breast IrradiationClinical Breast Cancer, 2016
- The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activityMolecular and Cellular Biochemistry, 2015
- Expression of osteopontin, a target gene of de‐regulated Wnt signaling, predicts survival in colon cancerInternational Journal of Cancer, 2007